Passage BIO, Inc. SEC filings PASG
Passage BIO, Inc. has 443 filings in SEC EDGAR's recent list, going back to Sep 6, 2019. Its latest annual report, Form ARS, was filed on Apr 7, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 10, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 6, 2026 (officer or director change, shareholder vote results). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B3 | Prospectus | Oct 9, 2026 | — |
| S-4/A | Filing | Oct 8, 2026 | — |
| S-4/A | Filing | Oct 5, 2026 | — |
| S-4/A | Filing | Sep 21, 2026 | — |
| S-4/A | S-4a | Sep 3, 2026 | — |
| S-4 | Registration for a merger or exchange | Jul 21, 2026 | — |
| S-8 | Employee stock plan registration | Mar 4, 2026 | — |
| 424B5 | Prospectus supplement | Mar 5, 2025 | — |
| S-8 | Employee stock plan registration | Mar 5, 2025 | — |
| 424B3 | Prospectus | May 14, 2024 | — |
| S-8 | Employee stock plan registration | Mar 4, 2024 | — |
| S-3 | Shelf registration | Mar 4, 2024 | — |
| S-8 | Employee stock plan registration | Mar 6, 2023 | — |
| POS AM | Filing | Mar 3, 2022 | — |
| S-8 | Employee stock plan registration | Mar 3, 2022 | — |
| POS AM | Filing | Mar 3, 2022 | — |
| S-8 | Employee stock plan registration | Jul 19, 2021 | — |
| S-3ASR | Automatic shelf registration | Mar 5, 2021 | — |
| S-8 | Employee stock plan registration | Mar 5, 2021 | — |
| 424B1 | Filing | Jan 22, 2021 | — |
| S-1 | Registration statement | Jan 19, 2021 | — |
| 424B4 | Prospectus | Feb 28, 2020 | — |
| S-8 | Employee stock plan registration | Feb 28, 2020 | — |
| S-1MEF | Filing | Feb 27, 2020 | — |
| S-1/A | Amended registration statement | Feb 27, 2020 | — |
| FWP | Free writing prospectus | Feb 20, 2020 | — |
| S-1/A | Amended registration statement | Feb 18, 2020 | — |
| S-1 | Registration statement | Feb 3, 2020 | — |
Showing 28 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- PASG (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Philadelphia, PA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1787297
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.